Prateek Khanna
@DrPrateekKhanna
Followers
38
Following
209
Statuses
19
Early career physician scientist @DanaFarber. Research focus in rare kidney cancer. Opinions are my own.
Boston, MA
Joined November 2024
Starting @X journey! Grateful to be recognized as the inaugural Dr. Nizar Tannir Rare Kidney Cancer Scholar #IKCS2024 @KidneyCancer. Looking forward to mentorships with #NizarTannir @PavlosMsaouel. Special thanks to my mentors @srviswanathan @VincentWenxinXu @DrChoueiri !!
8
5
22
This is a big step for personalized cancer vaccines in kidney cancer!! Congrats @DrChoueiri @BraunMDPhD
1/ JUST IN: an 8 year #kidneycancer journey now published in @Nature: “A personalized neoantigen vaccine generates anti-tumor immunity in high-risk renal cell carcinoma”. A trial of #RCC vaccine, led together with first author @BraunMDPhD @YaleCancer and #PatrickOtt #DerinKeskin #CatherineWu @DanaFarber
@DanaFarber_GU @OncoAlert @DFCI_NeoVax
0
0
0
RT @ALLIANCE_org: New Trial Alert! .@BradMcG04 @DanaFarber leads @ALLIANCE_org A032201 (STRIKE) to compare the effect of adding tivozanib t…
0
10
0
RT @OncLive: Nivolumab Plus Ipilimumab May Offer Efficacious Therapeutic Approach in Rare GU Cancers @BradMcG04 @DanaFarber_GU @DanaFarber…
0
3
0
RT @DanaFarberNews: Belzutifan plus cabozantinib shows promising antitumor activity in patients with clear-cell renal cell carcinoma who we…
0
12
0
RT @VincentWenxinXu: 1/8 Our study on natural killer (NK) cell dysfunction in kidney cancer is now out @ESMO_open! Led by co-first authors…
0
22
0
RT @DrChoueiri: Our @DanaFarber_GU colleague @srviswanathan awarded today the Team Science Award for his basic work on X chromosome and tra…
0
12
0
0
0
1
RT @DrChoueiri: JUST IN: Very important paper by the @US_FDA about 2024 drug approvals published in @NatRevDrugDisc by science writer extra…
0
35
0
RT @DrChoueiri: 1/ Results from #LITESPARK-003 cohort 1 (1st Line) are out @TheLancetOncol! This phase II trial examined HIF2 inh Belzutifa…
0
40
0
RT @Larvol: The 2024 edition of the Top Oncologists on X for Genitourinary (GU) Cancers is here! Peer-nominated for their influence and ded…
0
17
0
RT @DrChoueiri: Paper 5 KIDNEY Achom et al. conducted haplotype-specific analyses of chrX rearrangements in tRCC whole genomes, demonstrat…
0
6
0
RT @Histo_Journal: TFE3‐rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape - Agaimy - Hist…
0
18
0
RT @nataliagandur: 💫🌟Treatment options for patients with metastatic papillary RCC🌟💫 @lisapic #RenalC24 #RENALC24 @OncoAlert @mirrorsmed 📌 …
0
17
0
RT @DanaFarber_GU: Congratulations to Lank Center investigators Joaquim Bellmunt (@OncoBellmunt) and Matthew Vander Heiden (@mvh_lab) for b…
0
10
0
Congratulations @SimonGarinet & @KarlSemaan @srviswanathan @SylvanBacaLab. Drs. Garinet and Semaan have shown that it’s possible to detect the presence of translocation kidney cancer in patient’s blood through epigenomic profiling.
Excited to share our work at #AACR #liquidbiopsy. Amazing science presented at the conference. #SanDiego
@KarlSemaan @srviswanathan @DrChoueiri @SylvanBacaLab
0
1
3
RT @drenriquegrande: ⚡️ @JCO_ASCO - Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozan…
0
26
0
@DrChoueiri @KHCFKHCC @GhidaTalal @DanaFarberNews @DanaFarber_GU @DanaFarber @harvardmed @Harvard @khcfusa @ASCO @myESMO @ESMO_Open @OncJournal Congratulations!!
0
0
0
RT @KidneyCancer: Heather Williams faced the unimaginable — being diagnosed with a #RareKidneyCancer & discovering her pregnancy just 13 da…
0
4
0